Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, VIC, Australia.
Department of Molecular and Translational Sciences, Monash University, Clayton, VIC, Australia.
Methods Mol Biol. 2023;2691:111-120. doi: 10.1007/978-1-0716-3331-1_9.
Silicosis is an untreatable occupational lung disease caused by chronic inhalation of crystalline silica. Cyclical release and reuptake of silica particles by macrophages and airway epithelial cells causes repeated tissue damage, characterized by widespread inflammation and progressive diffuse fibrosis. While inhalation is the main route of entry for silica particles in humans, most preclinical studies administer silica via the intratracheal route. In vivo mouse models of lung disease are valuable tools required to bridge the translational gap between in vitro cell culture and human disease. This chapter describes a mouse model of silicosis which mimics clinical features of human silicosis, as well as methods for intranasal instillation of silica and disease analysis. Lung tissue can be collected for histological assessment of silica particle distribution, inflammation, structural damage, and fibrosis in sections stained with hematoxylin and eosin or Masson's trichrome. This approach can be extended to other chronic fibrotic lung diseases where inhalation of small damaging particles such as pollutants causes irreversible disease.
矽肺是一种无法治愈的职业性肺部疾病,由长期吸入结晶二氧化硅引起。巨噬细胞和气道上皮细胞周期性地释放和再摄取二氧化硅颗粒会导致反复的组织损伤,其特征是广泛的炎症和进行性弥漫性纤维化。虽然吸入是人类吸入二氧化硅颗粒的主要途径,但大多数临床前研究通过气管内途径给予二氧化硅。肺部疾病的体内小鼠模型是在体外细胞培养和人类疾病之间架起转化桥梁所需的有价值的工具。本章描述了一种模拟人类矽肺临床特征的矽肺小鼠模型,以及用于鼻腔内滴注二氧化硅和疾病分析的方法。可以收集肺组织,用于苏木精和曙红或 Masson 三色染色切片中评估二氧化硅颗粒分布、炎症、结构损伤和纤维化。这种方法可以扩展到其他慢性纤维性肺部疾病,其中吸入小的有害颗粒(如污染物)会导致不可逆转的疾病。